Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer
Abstract Background Based on the JCOG1109 trial, it is suggested that the combination of docetaxel, cisplatin, and 5‐fluorouracil (DCF) could potentially become a standard neoadjuvant chemotherapy regimen, alongside the conventional 5‐fluorouracil and cisplatin (CF) therapy, for esophageal cancer. H...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wiley
2024-08-01
|
| Seria: | Cancer Reports |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1002/cnr2.2084 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|